Although molecular alterations in the PI3K/Akt/mTOR pathway have been increasingly recognized in canine gliomas, reflecting similarities to the human counterpart, studies addressing abnormalities in PTEN expression are scarce. This evidence concerns the gene MTOR and central nervous system cancer.